Search - tctmd.com

Displaying 601 - 620 of 674

Sort: Relevancy | Date

News Daily News

Anemia Inhibits Platelet Response to Clopidogrel in PCI Patients

March 21, 2012

News Daily News

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

Yael L. Maxwell

March 15, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

March 07, 2012

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Caitlin E. Cox

March 07, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Daily News

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Caitlin E. Cox

March 06, 2012

News Daily News

Análisis PLATO: Los IBP son Problemáticos tanto con el Ticagrelor como con el Clopidogrel

Caitlin E. Cox

March 06, 2012

Presentation ISET 2012

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Presenter: Gunnar Tepe

January 17, 2012

News Daily News

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

L.A. McKeown

January 12, 2012

News Daily News

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

January 03, 2012

Presentation TCT 2012

Benefits of CD 34 Antibody Coated Stent in Patients with High Risk for Bleeding During Dual Antiplatelet Therapy.

Presenter: Miltiadis Papalexandris, Hubertus Degen, Carsten Stoepel, Thomas Lickfeld, Thorsten Schneider, Carlos Freitas, Michael Haude

January 03, 2012

Presentation TCT 2012

”Safety of Dual Antiplatelet Therapy in Patients Treated with Coronary Drug Eluting Stents.”

Presenter: Andrzej Drewnicki, Maciej Lesiak, Malgorzata Pyda, Marek Grygier, Wlodzimierz Skorupski, Aleksander Araszkiewicz, Przemyslaw Mitkowski, Stefan Grajek

January 03, 2012

News Conference News

ACCEL-BLEED: Mild Bleeding Correlated with Platelet Reactivity One Month Post PCI

November 22, 2011

News Conference News

SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel

November 21, 2011

News Conference News

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

November 16, 2011

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Daily News

Genetic Predictors of Early Stent Thrombosis Identified

L.A. McKeown

October 25, 2011

News Daily News

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Jason Kahn

October 24, 2011

Advertisement

Anemia Inhibits Platelet Response to Clopidogrel in PCI Patients

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

TCTMD’s Top 10 Most Popular News Stories From 2011

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Análisis PLATO: Los IBP son Problemáticos tanto con el Ticagrelor como con el Clopidogrel

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

Benefits of CD 34 Antibody Coated Stent in Patients with High Risk for Bleeding During Dual Antiplatelet Therapy.

”Safety of Dual Antiplatelet Therapy in Patients Treated with Coronary Drug Eluting Stents.”

ACCEL-BLEED: Mild Bleeding Correlated with Platelet Reactivity One Month Post PCI

SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

Genetic Predictors of Early Stent Thrombosis Identified

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content